Evidence map›Paper›PMID 21852765›Full record

ArticleMolecules (Basel, Switzerland)2011

Activity and stability studies of verbascoside, a novel antioxidant, in dermo-cosmetic and pharmaceutical topical formulations.

Silvia Vertuani, Erika Beghelli, Emanuela Scalambra, Gemma Malisardi, Stefano Copetti, Roberto Dal Toso, Anna Baldisserotto, Stefano Manfredini

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
10.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 143 citations in OpenAlex.

  1. Trial
  2. Review
  3. Cells · 2026
    Article
  4. Chemical Composition and Bioactivities of TurkishMolecules (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Article
  7. Verbascoside-richFrontiers in bioengineering and biotechnology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Assessment of the Effect ofClinical, cosmetic and investigational dermatology · 2024
    Article
  17. Article
  18. Up-Cycling ofLife (Basel, Switzerland) · 2023
    Article
  19. Article
  20. Plants (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Silvia VertuaniDepartment of Pharmaceutical Sciences, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy. vrs@unife.it
Erika Beghelli
Emanuela Scalambra
Gemma Malisardi
Stefano Copetti
Roberto Dal Toso
Anna Baldisserotto
Stefano Manfredini
University of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We here report the results of our investigations carried out on verbascoside, a phenylpropanoid glycoside known for its antioxidant, anti-inflammatory and photoprotective actions. Verbascoside was obtained from Buddleia davidii meristematic cells, obtained in turn using a sustainable biotechnology platform which employs an in vitro plant cell culture technology. Verbascoside was first investigated to assess the behaviour of the active ingredient in solution or in finished preparations, in view of its potential topical use, especially in skin protection. Stability studies were performed by HPLC, and a PCL assay was adopted to determine the radical scavenging activity toward superoxide anion. The high hydrophilic character of verbascoside, suggested in a somewhat limited range of possible applications, leading us to explore its derivatization to obtain the semi-synthetic derivative VPP, an acyl derivative of verbascoside, with an improved range of applications due to its lower hydrophilic profile. Alone, VPP revealed increased antioxidant activity, both as an active ingredient and in dermocosmetic preparations. Stability studies showed a greater stability of VPP in lipophilic vehicles, whereas the parent verbascoside proved more stable in an O/W emulsions. Verbascoside was also stable in suppositories, an interesting pharmaceutical form for possible applications in treatment of inflammation of the intestinal mucosa.

Indexed as

AntioxidantsCosmeticsGlucosidesPhenolsAdministration, TopicalBuddlejaChemistry, PharmaceuticalChromatography, High Pressure LiquidDrug StabilityEmulsionsExcipientsHumansHydrophobic and Hydrophilic InteractionsInflammationIntestinal MucosaLuminescenceacteosideAntioxidantsCosmeticsEmulsionsExcipientsGlucosidesPhenolsPolyphenolsSuperoxidesSuppositories

Identifiers

PMID21852765
PMCPMC6264555
OpenAlexW2155908752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.